Schedule 13G ownership disclosure

PIERIS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 720795103

Event date: 2022-01-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-22-019851
Form type
SC 13G
Filer
PALVELLA THERAPEUTICS, INC.
CIK
CIK 1583648
Filed
Jan 27, 2022
Reporting period
Jan 24, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub